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INTRODUCTION
Neonatal early-onset sepsis (EOS) is defined as the 
onset of sepsis within the first 72 hours of life.1 
Group B Streptococci (GBS) or Escherichia 
coli that colonize the maternal gastro-
intestinal or genitourinary tract are the 
most common pathogens responsible for 
the development of EOS.2 Until recently, 
guidelines published by the Centers for 
Disease Control and Prevention (CDC) 
and the American Academy of Pediatrics 
(AAP), have been the gold standard resource 
utilized by clinicians for the management of 
EOS.1,3 These guidelines recommend empiric antibiotic 
initiation for all neonates who appear clinically ill at 
birth or who are born to a woman diagnosed 
with chorioamnionitis.
Consequences of early antibiotic exposure 
within the neonatal population include the 
development of necrotizing enterocolitis 
and invasive candidiasis as well as alter-
ations in the microbiome, illustrating the 
importance of determining an objective 
method to risk-stratify neonates more nar-
rowly.4–6 A movement referred to as “Triple 
I,” intrauterine inflammation, infection, or both, 
has been one proposed method of reducing unnec-
essary antibiotic exposure within neonates by utilizing a 
more objective approach to diagnose maternal chorioam-
nionitis.7 A multivariate prediction model was developed 
to better assess the true risk of EOS development within 
the neonatal population.8–10 This approach takes into 
account both maternal and neonatal objective data rather 
than relying exclusively on subjective findings, such as the 
presence or absence of neonatal clinical illness or maternal 
chorioamnionitis.
Studies utilizing this method have demonstrated a 
decrease in antibiotic exposure to uninfected neonates, 
blood culture draws with similar incidence rates of cul-
ture-positive sepsis, and no statistical difference in adverse 
events when compared with the CDC/AAP guidelines.11–13 
Impact of Integrating a Neonatal Early-Onset 
Sepsis Risk Calculator into the Electronic Health 
Record
Nyles T. Fowler, PharmD*; Michael Garcia,  PharmD*; Cynthia Hankins, PharmD, BCPS, BCPPS†
ABSTRACT
Introduction: Investigators from Kaiser Permanente developed a risk-assessment calculator as a tool for evaluation of early-onset 
sepsis (EOS) to narrow antibiotic use for the treatment of EOS. The integration of the EOS risk calculator into an electronic health 
record will minimize manual calculations and data entry and improve compliance and accuracy through automation. Methods: We 
performed a retrospective chart review for neonates ≥34 weeks and 0 days gestational age. We collected data pre-integration and 
post-integration of the EOS risk calculator. The primary outcome measure is the accuracy of user input into the calculator. Secondary 
outcomes include compliance with using the EOS risk calculator, impact on clinical recommendation when incorrectly calculated, 
assessment of antibiotic utilization rate (AUR), and comparison of EOS risk calculator recommendations with Centers for Disease 
Control and American Academy of Pediatrics recommendations. Results: Miscalculations occurred in 52% of instances pre-integra-
tion and 19% of instances post-integration; P < 0.001. Compliance was 93% pre-integration and 98% post-integration; P = 0.138. 
Clinical recommendations were changed for 21% (13/62) of miscalculations pre-integration and 4% (1/23) of miscalculations post-in-
tegration; P = 0.099. The AUR for combined NICU and nursery patients was 47 pre-integration and 47 post-integration; P > 0.999. 
Six cases of culture-positive sepsis were identified, and all recommendations generated by the EOS risk calculator were in alignment 
with current Centers for Disease Control/American Academy of Pediatrics treatment guidelines. Conclusions: Integration of the 
EOS risk calculator into the electronic health record significantly increased calculator accuracy, although it did not show statistically 
significant differences with regards to compliance, clinical recommendations, or AUR. (Pediatr Qual Saf 2019;4:e235; doi: 10.1097/
pq9.0000000000000235; Published online November 6, 2019.)
From the *Providence Portland Medical Center, Portland, Oreg.; and † Providence 
St. Vincent Medical Center, Portland, Oreg.
*Corresponding author. Address: Nyles T Fowler, PharmD, Providence Portland 
Medical Center, 4805 NE Glisan St, Portland, OR 97213
Email: nyles.fowler@providence.org. PH: 503-215-6080l Fax: 503-215-9392.
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. This 
is an open-access article distributed under the terms of the Creative Commons 
Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it 
is permissible to download and share the work provided it is properly cited. The 
work cannot be changed in any way or used commercially without permission 
from the journal.
To cite: Fowler NT, Garcia M, Hankins C.Impact of Integrating a Neonatal Early-
Onset Sepsis Risk Calculator into the Electronic Health Record. Pediatr Qual Saf 
2019;6:e235.
Received for publication April 30, 2019; Accepted October 18, 2019.
Published online  November 6, 2019
DOI: 10.1097/pq9.0000000000000235
EOS Risk Calculator Integration
2
Pediatric Quality and Safety
A previous study within our 2 healthcare centers identi-
fied a 69% reduction in recommended empiric antibiotics 
with the implementation of the EOS risk calculator.11 In 
another study, implementation of the EOS risk calculator 
reduced empiric antibiotic use for EOS by 42%.13 These 
findings suggest that applying this risk calculator is a safe 
approach that can be utilized within this clinical setting to 
reduce the number of uninfected neonates administered 
empiric antibiotics.
The value of the integration of decision-making tools 
directly into the electronic health record (EHR) has been 
previously reported. A recent study integrated and then 
further improved integration of a decision-making tool 
into the EHR resulting in improved utilization of the de-
cision-making tool and a decrease in frequency of anti-
biotic prescribing.14 McGinn et al successfully integrated 
a decision-making tool into an EHR, which resulted in 
improved compliance, a reduction in antibiotic utiliza-
tion, and reduction in point-of-care testing.15 Another 
study evaluating the integration of a decision-making tool 
resulted in a significant decrease in unnecessary testing, 
with no associated increase in clinically important misdi-
agnoses or a decrease in physician satisfaction.16
Initial implementation of the EOS risk calculator within 
our healthcare system required manual data entry of pa-
tient information into the EOS risk calculator. Clinicians 
accessed the EOS risk calculator (https://neonatalsepsis-
calculator.kaiserpermanente.org/) through a direct link 
incorporated within the EHR. Utilization of the EOS 
risk calculator resulted in increased workload, noncom-
pliance, and miscalculations, leading to suboptimal uti-
lization of the EOS risk calculator tool. Approximately 
1 year following implementation, we integrated the EOS 
risk calculator directly into the EHR to automate the pro-
cess and minimize the need for manual data collection 
and imputation.
The objective of this study is to evaluate the impact of 
the integration of the EOS risk calculator into the EHR. 
As above, many studies have validated the utility of im-
plementation of this decision-making tool but have not 
compared the accuracy, compliance, the impact of impu-
tation errors, or difference in antibiotic utilization rates 
(AURs) of the manual imputation of patient-specific data 
into the EOS risk calculator to an automated process. We 
hypothesize that the integration of the EOS risk calcu-
lator into the EHR will minimize manual data entry for 
calculation and improve compliance, accuracy, and anti-
biotic utilization through automation.
METHODS
Study Design
We conducted a retrospective observational review of 
neonates older than 34 weeks and 0 days gestational age 
within 2 large tertiary teaching hospitals. A total of 12 
months of data were extracted with 6 months of data col-
lected pre-EOS risk calculator integration from May 2017 
to October 2017 and 6 months of data collected post-
EOS risk calculator integration from December 2017 to 
May 2018. This study was compliant with the Guidelines 
for Human Experimentation from the US Department of 
Health and Human Services and received approval from 
the Institutional Review Board. All data collected were 
de-identified to maintain the confidentiality of all study 
subjects, and no informed consent was required due to 
the nature of the study design.
The patient population was generated through Epic 
and Tableau reporting systems, and we completed the 
chart review for each patient and the patient’s mother. 
Data were collected pre-integration and post-integration 
of the EOS risk calculator. A total of 20 patients were 
randomly selected and evaluated each month (10 from 
NICU, 10 from nursery).
To assess for the primary and secondary study objec-
tives, we included in the neonatal data collection total ad-
mission days, gestational age, risk calculator score, clinical 
illness, and blood culture and susceptibilities. Maternal 
data collection included intrapartum temperature, dura-
tion of rupture of membranes, vaginal versus cesarean de-
livery, GBS status, and administration of perinatal GBS 
prophylaxis. Signs and symptoms of clinical illness were 
abstracted, and we classified patients as having a clinical 
illness, equivocal appearance, or well-appearing status 
according to documentation by medical providers and 
definitions described by risk calculator authors (available 
at https://neonatalsepsiscalculator.kaiserpermanente.org/
classification.aspx). We calculated neonatal sepsis risk per 
1,000 live births using a baseline incidence of 0.3 cases 
of sepsis per 1,000 live births, as this is closest to our 
healthcare system EOS rate of 0.26 cases of sepsis per 
1,000 live births reported in 2015. EOS risk calculator 
recommendations for empiric antibiotics, blood cultures, 
and vital sign monitoring according to clinical status were 
recorded for each subject.
The primary outcome measure is the accuracy of the 
EOS risk calculator imputation. Secondary outcomes in-
clude compliance with the utilization of the EOS risk 
calculator, impact on clinical recommendation when 
incorrectly calculated, assessment of AUR (antibiotic 
days/1,000 patient admission days), and comparison 
of EOS risk calculator recommendations with CDC/
AAP recommendations for all positive EOS cultures. 
Statistical analysis was completed using Fisher’s Exact 
Test. A resulting P value < 0.05 was considered statisti-
cally significant.
Implementation of the EOS Risk Calculator
The healthcare system’s Women and Children Clinical 
Performance Group assembled a Triple I and Early Onset 
Sepsis Workgroup in December 2015 to improve the 
identification of infants at risk for EOS. In May 2016, 
the Workgroup established the utilization of the EOS risk 
calculator and incorporated a link to the EOS risk calcu-
lator website into the EHR. Also, the EOS risk calculator 
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infection screening parameters and nurse process instruc-
tions were added to the EHR newborn admission order 
set. A Triple I/Early Onset Sepsis Toolkit providing EOS 
risk calculator education was finalized in August 2016 
and distributed in September 2016. Additional EOS risk 
calculator education was provided to Neonatal Nurse 
Practitioners at both Hospital A and Hospital B during 
September 2016. An EOS risk calculator “help card” was 
created and utilized by staff in Hospital B for calculator 
data imputation. Copies of the “help card” were placed at 
every computer workstation. Hospital B utilized a Nurse 
Clinical Educator to provide EOS risk calculator educa-
tion to nursing staff within the nursery unit. EOS risk cal-
culator utilization began in October 2016 in Hospital A, 
and November 2016 in Hospital B. An EOS risk calcula-
tion was to be performed following delivery on every neo-
nate delivered older than 34 weeks and 0 days gestational 
age regardless of symptoms. Implementation of the EOS 
risk calculator required manual data collection and impu-
tation of patient-specific data by the end-user (labor nurse 
or provider). Staff manually documented the EOS risk at 
birth score determined by the EOS risk calculator in the 
EHR newborn delivery summary. Providers were notified 
if the calculated EOS risk score was >0.65/1,000 births or 
if the EOS risk calculator recommended the acquisition 
of a blood culture.
Integration of the EOS Risk Calculator
In November 2017, the healthcare system informatics/
application analyst team integrated the EOS risk calcu-
lator into the EHR. This integration provided automa-
tion and standardization to the EOS risk calculation. The 
Workgroup provided updated EOS risk calculator educa-
tion to all staff. Hospital B continued to utilize a Nurse 
Clinical Educator to provide education to nursing staff 
within the nursery unit.
Following newborn delivery, the end-user calculates 
the EOS risk score using the EOS risk calculator located 
within the EHR newborn delivery summary, reviews the 
patient-specific data automatically collected for EOS risk 
calculation, and accepts the resulting EOS risk score into 
the patient EHR. The EOS risk score and patient-specific 
data are displayed in both the maternal and neonatal 
patient EHR. A smart link was developed to include 
the EOS risk score into progress note documentation. 
Nursing staff continued to notify providers if the cal-
culated EOS risk score was >0.65/1,000 births or if the 
EOS risk calculator recommended the acquisition of a 
blood culture.
RESULTS
We identified a total of 252 patients during the 12-month 
study period. EOS Risk Calculator data were incorrectly 
input by users in 52% of instances pre-integration, and 
the EOS risk calculator data were either auto-populated 
incorrectly or adjusted by users incorrectly in 19% of 
instances post-integration (P < 0.001). When we charac-
terized results further, there was not a statistically signif-
icant difference in miscalculations for Hospital A NICU 
(P = 0.2882). The EOS risk calculator was utilized in 
93% of patients pre-integration and 98% of patients 
post-integration (P = 0.138). EOS risk calculator clin-
ical recommendations were changed for 21% (13/62) of 
miscalculations pre-integration and 4% (1/23) of mis-
calculations post-integration (P = 0.099). One patient 
(1/13) pre-integration had a changed clinical recom-
mendation due to the EOS risk calculator miscalcula-
tion and classification category (Table  1). The result-
ing miscalculation recommended a blood culture and 
CBC, whereas a correct calculation recommended no 
culture and no antibiotics with routine vitals monitor-
ing. The remaining 12 patients had no change in clinical 
recommendation, despite a miscalculation. The most 
commonly associated reasons for score miscalculations 
pre-integration and post-integration included incorrect 
Table 1. Impact of Integration of Neonatal EOS Risk Calculator
Location  Pre-Integration Post-Integration P
NICU+nursery Compliance, N (%) 120 (93.0%) 119 (97.5%) 0.138
 Incorrect calculation, N (%) 62 (51.7%) 23 (19.2%) <0.001
 Clinical recommendation changed, N (%) 13 (21.0%) 1 (4.3%) 0.099
NICU Compliance, N (%) 60 (90.9%) 60 (96.8%) 0.2753
 Incorrect calculation, N (%) 29 (48.3%) 14 (23.3%) 0.0073
 Clinical recommendation changed, N (%) 8 (27.6%) 1 (7.1%) 0.2307
Nursery Compliance, N (%) 60 (95.2%) 60 (98.4%) 0.619
 Incorrect calculation, N (%) 33 (55%) 9 (15%) <0.00001
 Clinical recommendation changed, N (%) 5 (15.2%) 0 (0%) 0.5671
Hospital A NICU Compliance, N (%) 30 (93.8%) 30 (93.8%) 1
 Incorrect calculation, N (%) 14 (46.7%) 9 (30%) 0.2882
 Clinical recommendation changed, N (%) 4 (28.6%) 0 (0%) 0.1273
Hospital B NICU Compliance, N (%) 30 (88.2%) 30 (100%) 0.1161
 Incorrect calculation, N (%) 15 (50%) 5 (16.7%) 0.0127
 Clinical recommendation changed, N (%) 4 (26.7%) 1 (20%) 1
Hospital A Nursery Compliance, N (%) 30 (96.8%) 30 (100%) 1
 Incorrect calculation, N (%) 17 (56.7%) 3 (10%) 0.0003
 Clinical recommendation changed, N (%) 0 (0%) 0 (0%) 1
Hospital B Nursery Compliance, N (%) 30 (93.8%) 30 (96.8%) 1
 Incorrect calculation, N (%) 16 (53.3%) 6 (20%) 0.015
 Clinical recommendation changed, N (%) 5 (31.3%) 0 (0%) 0.2663
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evaluation of highest maternal temperature (35%), du-
ration of rupture of membranes (31%), timing/type 
of intrapartum antibiotics (15%), and maternal GBS 
status (14%) (Table 2).
We calculated the AUR from an identified 10,558 pa-
tient admission days with a total of 498 days of antibiotic 
therapy pre-integration and 10,119 patient admission 
days with a total of 477 antibiotic therapy days post-in-
tegration. The AUR for combined NICU and nursery 
patients was 47 pre-integration and 47 post-integra-
tion (P > 0.999). For NICU patients, the AUR was 164 
pre-integration and 169 post-integration (P = 0.729). For 
nursery patients, the AUR was 13 pre-integration and 11 
post-integration (P = 0.377, Table 3).
We identified 6 cases of confirmed culture-positive 
sepsis throughout the 12-month study period. All recom-
mendations generated by the EOS risk calculator for each 
of the 6 cases of culture-positive sepsis identified were 
in alignment with recommendations from current CDC/
AAP treatment guidelines for the initiation of empiric 
antibiotics (Table 4).
DISCUSSION
In this retrospective analysis, the EHR integration of the 
Kaiser Permanente neonatal EOS risk calculator signifi-
cantly increased calculator accuracy. The integration of 
the EOS risk calculator resulted in an insignificant in-
crease in calculator utilization and an insignificant de-
crease in the occurrence of changed clinical recommen-
dations following miscalculations. Only 1 patient with a 
miscalculation was directly impacted by the changed clin-
ical recommendation after categorization of the clinical 
presentation following examination. All other patients 
with a miscalculation, which resulted in a changed clin-
ical recommendation, were not directly impacted. For 
these patients, the changed clinical recommendation was 
not for the specific clinical presentation classification that 
categorized these patients following clinical examination.
In a recent study, EOS risk calculator integration 
increased compliance from 59% to 85% and decreased 
the frequency of antibiotic prescribing from 7% to 1%.14 
Within the study, the EOS risk calculator was integrated 
and then improved, but was not fully automated. We at-
tribute our higher pre-integration utilization percentage 
to extensive education and guidance provided from a de-
veloped Triple I/Early Onset Sepsis Toolkit distributed 
throughout our entire healthcare system before EOS risk 
calculator implementation.
Accuracy in the utilization of the EOS risk calculator as 
a clinical decision-making tool in the setting of neonatal 
EOS is imperative. The utility of the tool decreases if not 
appropriately utilized, and inaccuracies may directly in-
fluence the management of a neonate with possible EOS. 
Incorrect utilization of this tool has the potential to inap-
propriately identify cases of EOS, leading to missed cases 
of true EOS as well as inappropriate antibiotic utilization 
and laboratory monitoring.
Hospital B provided staff education, a calculator “help 
card,” and utilized a Nurse Clinical Educator within the 
nursery unit during both pre- and post-EOS risk calcu-
lator integration phases. In the Hospital B nursery unit, a 
pharmacist reviewed identified calculator errors post-EOS 
risk calculator integration. A Nurse Clinical Educator 
provided education to individual staff. Select cases of 
identified errors were also reviewed by the healthcare 
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MAT, maternal antepartum temperature; ROM, rupture of membranes; IAP, intra-
partum antibiotic prophylaxis.








days per 1,000 
patient-days) P
NICU 164 169 0.729
Nursery 13 11 0.377
NICU+Nursery 47 47 >0.999
Table 4. Incidence of Culture-Positive Sepsis
Patient (n = 6) 1 2 3 4 5 6
Gestational Age (wk + d) 41 + 4 37 + 6 39 + 0 39 + 2 34 + 1 34 + 1
Highest MAT (°F) 100.7 98.6 100.4 102.7 99 99.1
Duration of ROM (h) 16 21 12 14 197 322
GBS status Unknown Negative Negative Negative Negative Positive
IAP given None None None None None None
Patient clinical status Clinical illness Clinical illness Clinical illness Clinical illness Clinical illness Clinical illness
Risk of EOS based on  
patient clinical status
19.07 2.98 8.96 65.04 130.89 252.15
Neonatal sepsis calculator  
recommendations
Empiric antibiotics Strongly consider 
antibiotics
Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics
CDC/AAP recommendations Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics Empiric antibiotics
MAT, maternal antepartum temperature; ROM, rupture of membranes; IAP, intrapartum antibiotic prophylaxis.
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system analyst team. We found that both Hospital A and 
Hospital B nursery units had similar rates of miscalcula-
tions pre-integration. Hospital A nursery unit showed a 
greater improvement in miscalculations post-integration, 
further confirming the necessity for EOS risk calculator 
integration to improve calculator accuracy.
We have identified several limitations of this study. First, 
the monthly evaluation of EOS risk calculator results was 
only from a small portion of neonates. Systematic evalua-
tion in a prospective fashion of a larger population would 
help further identify the impact of EOS risk calculator 
miscalculations. There are also multiple limitations to the 
integration of the EOS risk calculator itself. With the in-
tegration, maternal and neonatal information is automat-
ically collected and displayed for the user, but within our 
healthcare centers, there is still an opportunity for indi-
vidual data manipulation by the user before acceptance 
of results. Providing education to healthcare providers on 
how to appropriately utilize any decision-making tool is 
paramount.
Within both Hospital A and Hospital B, the most com-
mon miscalculations were due to incorrect imputation 
of the highest maternal antepartum temperature and the 
duration of rupture of membranes. The EOS risk calcu-
lator requires the entry of 6 variables to perform a risk 
calculation. Without proper education, these variables 
can be incorrectly input, resulting in a miscalculation of 
the EOS risk score and possible incorrect clinical recom-
mendation. The first variable, the incidence of EOS, has 
12 possible incidence rates from which to select. This list 
allows a hospital or healthcare system to select an EOS 
incidence rate closely matching their own. Our health-
care system uses an EOS incidence rate of 0.3/1,000 live 
births, and following EOS risk calculator implementa-
tion, required the end-user to select the correct EOS inci-
dence rate manually. The incidence rate of 0.5/1,000 live 
births listed within the EOS risk calculator selection menu 
states “CDC national incidence” and has led to confusion 
among some end-users who were unaware of our health-
care system EOS incidence rate. Following EOS risk cal-
culator integration, the calculator automatically defaults 
the EOS incidence rate to 0.3/1,000 live births.
Gestational age is recorded in the EOS risk calculator 
as weeks and days, with a range of 34 to 43 weeks. The 
EOS risk calculator will not calculate an EOS risk score 
if clinicians enter a gestational age outside of this range. 
With EOS risk calculator integration, gestational age cor-
rectly auto-populates both fields and will not calculate if 
the gestational age is outside the defined range.
Implementation of the EOS risk calculator required the 
end-user to review numerous days of chart documenta-
tion to identify the highest recorded maternal antepartum 
temperature within an appropriate time frame. With EOS 
risk calculator integration, the highest maternal ante-
partum temperature within the previous 7 days before 
delivery is now auto-populated into the EOS risk calcu-
lator. Following integration, we have identified instances 
where the end-user overrode the auto-populated highest 
maternal antepartum temperature and selected a temper-
ature recorded either beyond 7 days before delivery or 
during the postpartum period.
During the implementation phase of the EOS risk cal-
culator, end-users would often enter or round the dura-
tion of rupture of membranes incorrectly. This problem 
was resolved with the integration of the EOS risk calcu-
lator as the automated EOS risk calculator auto-popu-
lates the duration of the rupture of membranes input field 
with information from the delivery summary.
With EOS calculator implementation, the end-user was 
required to determine maternal GBS status and correctly 
select negative, positive, or unknown within the EOS risk 
calculator. The EOS risk calculator “help card” used at 
Hospital B instructed the end-user to select maternal GBS 
status unknown if a negative GBS culture was drawn 
older than 5 weeks before the time of delivery. This rec-
ommendation is in agreement with revised CDC guide-
lines, which state the negative predictive value of GBS 
cultures declines if performed older than 5 weeks before 
delivery.3 Following EOS calculator integration, automa-
tion incorporates the 5-week GBS collection timeframe 
into the maternal GBS status decision-making process. 
We have identified instances post-integration where the 
maternal GBS status was adjusted by the end-user from 
unknown to negative based on progress note documenta-
tion or GBS culture result regardless of being reported as 
negative older than 5 weeks from time of delivery.
Education on the selection of intrapartum antibiotics 
was provided in the Triple I/Early Onset Sepsis Toolkit 
distributed across the entire healthcare system. Additional 
information was provided within the EOS risk calculator 
“help card” utilized at Hospital B. One challenge identi-
fied following the implementation of the EOS risk calcu-
lator was the proficiency of the end-user to appropriately 
classify antibiotics and/or antibiotic combinations as ei-
ther GBS specific or broad-spectrum antibiotics. Also, the 
end-user had to consider the timing of antibiotic admin-
istration. With the integration of the EOS risk calculator, 
automation correctly identified intrapartum antibiotic 
classification based on the type of antibiotics and the tim-
ing of antibiotic administration. We identified instances 
post-integration where end-users adjusted the type of 
intrapartum antibiotics selected through the automation 
process.
There was no significant change in the AUR throughout 
the study period pre- and post-integration of the EOS risk 
calculator. Additionally, in all 6 cases of confirmed cul-
ture-positive sepsis, the EOS risk calculator recommended 
utilization of antibiotics consistent with the CDC/AAP 
guideline criteria, and correctly identified true cases of 
infection.
EOS of the newborn remains a challenging clinical di-
lemma due to its relative rarity, high mortality, and lack 
of highly specific biomarkers. The integration of the 
Kaiser Permanente neonatal EOS calculator as a clinical 
EOS Risk Calculator Integration
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tool into the EHR significantly reduces the number of 
miscalculations.
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